BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Kudryavtseva A, Krasnov G. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World J Gastroenterol 2022; 28(10): 1067-1077 [PMID: 35431497 DOI: 10.3748/wjg.v28.i10.1067]
URL: https://www.wjgnet.com/1007-9327/full/v28/i10/1067.htm
Number Citing Articles
1
Irina Efremova, Roman Maslennikov, Elena Poluektova, Ekaterina Vasilieva, Yury Zharikov, Andrey Suslov, Yana Letyagina, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Epidemiology of small intestinal bacterial overgrowthWorld Journal of Gastroenterology 2023; 29(22): 3400-3421 doi: 10.3748/wjg.v29.i22.3400
2
Ya-Nan Li, Na-Ling Kang, Jia-Ji Jiang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng, Fei Wang. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changesWorld Journal of Gastroenterology 2022; 28(35): 5188-5202 doi: 10.3748/wjg.v28.i35.5188
3
Irina Efremova, Roman Maslennikov, Aliya Alieva, Elena Poluektova, Vladimir Ivashkin. Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in CirrhosisMicroorganisms 2023; 11(4): 1017 doi: 10.3390/microorganisms11041017
4
Qi-Qi Xie, Jia-Feng Wang, Yang-Fen Zhang, Dong-Hui Xu, Bo Zhou, Ting-Hui Li, Zhi-Peng Li. Glucose substrate in the hydrogen breath test for gut microbiota determination: A recommended noninvasive testWorld Journal of Clinical Cases 2022; 10(26): 9536-9538 doi: 10.12998/wjcc.v10.i26.9536
5
Shiqi Zhang, Pinglan Li, Suwon Lee, Yu Wang, Chunming Tan, Nan Shang. Weizmannia coagulans: an Ideal Probiotic for Gut Health Food Science and Human Wellness 2023; : 1 doi: 10.26599/FSHW.2022.9250002
6
André Pontes-Silva, André Luiz Lopes, Erika da Silva Maciel, Fernando Rodrigues Peixoto Quaresma, Almir Vieira Dibai-Filho. Human metabolism and body composition: prospects for novel studiesNutrition Reviews 2023; 82(1): 5 doi: 10.1093/nutrit/nuad040
7
Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova, Vladimir Ivashkin. Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled StudyJournal of Clinical Medicine 2024; 13(3): 919 doi: 10.3390/jcm13030919
8
D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potentialDokazatel'naya gastroenterologiya 2022; 11(4): 65 doi: 10.17116/dokgastro20221104165
9
Aneta Kiecka, Marian Szczepanik. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probioticsPharmacological Reports 2023; 75(4): 791 doi: 10.1007/s43440-023-00489-x
10
Yu. N. Alekhin, V. S. Ponamarev, O. S. Popova. Pathogenetic bases of the combined use of drugs from the groups of hepatoprotectors and phytosorbentsInternational Journal of Veterinary Medicine 2022; (2): 47 doi: 10.52419/issn2072-2419.2022.2.47
11
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiotaWorld Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
12
Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosisWorld Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525